Pfizer reported that Lyrica didn't satisfy the top effectiveness goal of a Phase III trial for treating patients with diabetic peripheral neuropathy.
Lyrica not effective for diabetic neuropathy pain
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan